Localized episcleral ALK-positive histiocytosis: a novel adult presentation confirmed by ALK gene rearrangement.

OrbitMay 19, 2026 (epub)

Latha K Abraham, Mobin Paul, Marian Pauly et al.

✦ AI-curated · Sources linked

Case in brief

A 36-year-old woman presented with an episcleral nodule that resembled nodular scleritis. An excisional biopsy revealed foamy histiocytes and Touton-type giant cells, with strong ALK1 expression and confirmed ALK gene rearrangement. Although a suspicious inguinal node was found, it was reactive. After excision, local recurrence occurred, and treatment with alectinib led to symptomatic improvement.

What made this case unusual

This case is notable for being the first documented instance of isolated episcleral ALK-positive histiocytosis in an adult, expanding the known anatomical spectrum of this condition.

Diagnostic / clinical pearl

Clinicians should consider ALK-positive histiocytosis in cases of atypical histiocytic infiltrates, particularly when presenting as ocular lesions.

Why it matters

Routine ALK1 screening in atypical histiocytic infiltrates can facilitate accurate diagnosis and enable access to targeted therapies, improving patient outcomes.

Source

Published in Orbit. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.